Compare BIO-TECHNE Corp (TECH) vs Sprott Uranium Miners ETF (URNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs Sprott Uranium Miners ETF — how do they compare? BIO-TECHNE Corp trades at $72.46 (market cap $11.37B), while Sprott Uranium Miners ETF trades at $46.4 (market cap $1.87B). The key difference: BIO-TECHNE Corp is far larger — about 6.1× Sprott Uranium Miners ETF's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Sprott Uranium Miners ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold BIO-TECHNE Corp for 63 Days and Sprott Uranium Miners ETF for 60 Days on average.
| TECH | URNM | |
|---|---|---|
Market Cap | $11.37B | $1.87B |
Volume | 3,153,511 | 495,553 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $72.61 | $83.99 |
52-Week Low | $43.31 | $46.09 |
Typical Hold Time | 63 Days | 60 Days |
Enterprise Value | $11.40B | — |
Dividend Yield | 0.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.
Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.
URNM (Sprott Uranium Miners ETF) trades at $47.87, down 4.83% today amid bearish technical signals. The ETF faces selling pressure with 13 bearish moving average indicators versus zero bullish signals. Despite the near-term weakness, uranium fundamentals remain strong with spot prices up 21.25% over the past year according to Sprott Asset Management data from August 2026. Recent government commitments to nuclear energy and AI-driven power demand create long-term growth catalysts.
The uranium sector faces near-term volatility but offers compelling long-term exposure to nuclear energy expansion. Key risks include uranium price fluctuations and regulatory uncertainty, while opportunities stem from $17.5 billion in U.S. nuclear funding and growing AI power needs. Analyst sentiment leans bullish on the sector's structural supply deficit and rising demand from data centers and government initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About Sprott Uranium Miners ETF
URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →
